Thomas F. Dejgaard
Copenhagen, Denmark
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 40 publications
Daily Glucagon-like Peptide-1 Receptor Agonists in Type 1 Diabetes: What we've Learned and What Comes Next.
Journal: Endocrinology and metabolism clinics of North America
Published: July 29, 2026
Effectiveness and Safety of Semaglutide in Type 1 Diabetes: A Danish Nationwide Cohort Study (2018-2024).
Journal: The Lancet regional health. Europe
Published: January 15, 2026
The Glucagonotropic Effect of GIP Is Negated During Insulin-Induced Hypoglycemia in Type 1 Diabetes: A Randomized, Placebo-Controlled, Crossover Study.
Journal: Diabetes
Published: December 17, 2025
Glucose-dependent insulinotropic polypeptide reduces postprandial glucose excursions but does not protect from hypoglycaemia in persons with type 1 diabetes-A randomised placebo-controlled study.
Journal: Diabetes, obesity & metabolism
Published: August 27, 2025
Repurposing colchicine for reduction of residual inflammatory risk in type 1 diabetes: Design and rationale of the REC1TE trial.
Journal: Diabetes, obesity & metabolism
Published: August 12, 2025
The Steno 1 study: Multifactorial intervention to reduce cardiovascular disease in type 1 diabetes-rationale and protocol of the prospective, randomized, open-labelled multicentre study.
Journal: Diabetes, obesity & metabolism
Published: May 09, 2025
Efficacy and safety of oral semaglutide treatment in a Danish type 2 diabetes outpatient clinic: Real-world evidence.
Journal: Diabetes, obesity & metabolism
Published: April 13, 2025
The Effect of Transition From Multiple Daily Injection Therapy to Automated Insulin Delivery in People With Type 1 Diabetes and Limited Diabetes Self-Management.
Journal: Journal of diabetes science and technology
Published: January 25, 2025
Liraglutide enhances insulin secretion and prolongs the remission period in adults with newly diagnosed type 1 diabetes (the NewLira study): A randomized, double-blind, placebo-controlled trial.
Journal: Diabetes, obesity & metabolism
Published: May 24, 2024
GIP Affects Hepatic Fat and Brown Adipose Tissue Thermogenesis but Not White Adipose Tissue Transcriptome in Type 1 Diabetes.
Journal: The Journal of clinical endocrinology and metabolism
Published: April 29, 2022
Endurance Training Improves GLP-1 Sensitivity and Glucose Tolerance in Overweight Women.
Journal: Journal of the Endocrine Society
Published: October 04, 2021
Liraglutide changes body composition and lowers added sugar intake in overweight persons with insulin pump-treated type 1 diabetes.
Journal: Diabetes, obesity & metabolism
Published: June 17, 2021
Last Updated: 09/26/2026